Research on Marketing Strategies of Product D — a Chronic
Myelogenous Leukemia Drug for Pharmaceutical Company A

亚洲社会药学 ›› 2020, Vol. 15 ›› Issue (3): 153-158.

Research on Marketing Strategies of Product D — a Chronic Myelogenous Leukemia Drug for Pharmaceutical Company A

Gu Pu, Wei Tingting, Wu Zhi’ang*

School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

出版日期:2020-09-20 发布日期:2020-09-15

Research on Marketing Strategies of Product D — a Chronic Myelogenous Leukemia Drug for Pharmaceutical Company A

Gu Pu, Wei Tingting, Wu Zhi’ang*

School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China

Online:2020-09-20 Published:2020-09-15
Contact: Wu Zhi’ang, professor. Major research area: pharmaceutical regulations and drug policies, etc. Tel: 18611552403, E-mail: 13940328503@139.com. E-mail:13940328503@139.com

摘要/Abstract

摘要： Objective To put forward some suggestions on the marketing strategies for chronic myelogenous leukemia in a pharmaceutical enterprise. Methods Based on the development status of the pharmaceutical industry and the SWOT analysis of a company’s product, the marketing strategies were formulated to provide theoretical basis for pharmaceutical enterprise to adapt to the new medical reform. Results and Conclusion Nowadays, due to fierce competition, in order to expand the new market, enterprises should implement the strategies of new products, centralized management and professional training. Meanwhile, the effective marketing strategies should be formulated and strictly carried out according to the conditions of the pharmaceutical company.

关键词: pharmaceutical company, chronic myelogenous leukemia, marketing strategy, economic benefit

Abstract: Objective To put forward some suggestions on the marketing strategies for chronic myelogenous leukemia in a pharmaceutical enterprise. Methods Based on the development status of the pharmaceutical industry and the SWOT analysis of a company’s product, the marketing strategies were formulated to provide theoretical basis for pharmaceutical enterprise to adapt to the new medical reform. Results and Conclusion Nowadays, due to fierce competition, in order to expand the new market, enterprises should implement the strategies of new products, centralized management and professional training. Meanwhile, the effective marketing strategies should be formulated and strictly carried out according to the conditions of the pharmaceutical company.

Key words: pharmaceutical company, chronic myelogenous leukemia, marketing strategy, economic benefit

Gu Pu, Wei Tingting, Wu Zhi’ang. Research on Marketing Strategies of Product D — a Chronic Myelogenous Leukemia Drug for Pharmaceutical Company A[J]. 亚洲社会药学, 2020, 15(3): 153-158.

Gu Pu, Wei Tingting, Wu Zhi’ang. Research on Marketing Strategies of Product D — a Chronic Myelogenous Leukemia Drug for Pharmaceutical Company A[J]. Asian Journal of Social Pharmacy, 2020, 15(3): 153-158.

[1]	Jia Fan, Tian Lijuan. Research on the Improvement of Incentive Mechanism for Pharmaceutical Sales Personnel - Taking Company A as an Example [J]. 亚洲社会药学, 2024, 19(3): 272-278.
[2]	Li Meng, Huang Zhe. Empirical Analysis on Performance Evaluation of A Pharmaceutical Company Based on Economic Value Added[J]. 亚洲社会药学, 2021, 16(2): 154-162.
[3]	Fu Geyang, Tian Lijuan. The Analysis of Marketing Strategy of Plendil[J]. 亚洲社会药学, 2020, 15(1): 37-43.
[4]	Wang Yujiao, Chen Yuwen. Antineoplastic Medicines in China: Market Characteristics and Marketing Strategies [J]. 亚洲社会药学, 2017, 12(4): 144-148.
[5]	BAI Jian;DAI Juan;LI Ye . Foreign Biological Reagent Enterprises in China:Marketing Concepts and Practices[J]. , 2015, 10(2): 79-81.

亚洲社会药学

Research on Marketing Strategies of Product D — a Chronic Myelogenous Leukemia Drug for Pharmaceutical Company A

Research on Marketing Strategies of Product D — a Chronic Myelogenous Leukemia Drug for Pharmaceutical Company A

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 5

编辑推荐

Metrics

本文评价